2018-2023 India Capecitabine Market Report (Status and Outlook)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 87

In 2017, the Capecitabine market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In India market, the top players include

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Split by product types/category, covering

- 500 mg

- 150 mg

Split by applications/end use industries, covers

- Breast Cancer

- Colorectal cancer

- Stomach Cancer

2018-2023 India Capecitabine Market Report (Status and Outlook)

Table of Contents

2018-2023 India Capecitabine Market Report (Status and Outlook)
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Market Segment by Types
1.2.1 India Capecitabine Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 India Capecitabine Sales Market Share by Types in 2017
1.2.3 500 mg
1.2.3.1 Major Players of 500 mg
1.2.4 150 mg
1.2.4.1 Major Players of 150 mg
1.3 India Capecitabine Market Segment by Applications/End Use Industries
1.3.1 India Capecitabine Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 India Capecitabine Sales Market Share by Applications in 2017
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 India Capecitabine Overview and Market Size (Value) (2013-2023)
1.4.1 India Market Capecitabine Overview
1.4.2 India Capecitabine Market Size (Value and Volume) Status and Forecast (2013-2023)
2 India Capecitabine Sales, Revenue (Value) and Market Share by Players
2.1 India Capecitabine Sales and Market Share by Players (2013-2018)
2.2 India Capecitabine Revenue and Market Share by Players (2013-2018)
2.3 India Capecitabine Average Price by Players in 2017
2.4 India Capecitabine Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Capecitabine Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 India Capecitabine Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 India Capecitabine Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 India Capecitabine Sales and Market Share by Type (2013-2018)
3.1.2 India Capecitabine Revenue and Market Share by Type (2013-2018)
3.1.3 India Capecitabine Price by Type (2013-2018)
3.2 India Capecitabine Sales and Market Share by Application (2013-2018)
3.3 India Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 India Capecitabine Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Capecitabine Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Teva
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Capecitabine Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Teva News
4.3 Mylan
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Capecitabine Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Mylan News
4.4 Hikma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Capecitabine Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Hikma News
4.5 Hengrui Medicine
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Capecitabine Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Hengrui Medicine News
4.6 Cipla
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Capecitabine Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Cipla News
4.7 Reliance Group
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Capecitabine Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Reliance Group News
4.8 Hetero
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Capecitabine Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Hetero News
5 India Capecitabine Market Forecast (2018-2023)
5.1 India Capecitabine Sales, Revenue and Price Forecast (2018-2023)
5.1.1 India Capecitabine Sales and Growth Rate Forecast (2018-2023)
5.1.2 India Capecitabine Revenue and Growth Rate Forecast (2018-2023)
5.1.3 India Capecitabine Price Trend Forecast (2018-2023)
5.2 India Capecitabine Sales Forecast by Type (2018-2023)
5.3 India Capecitabine Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Capecitabine
6.1 Main Raw Materials of Capecitabine
6.1.1 List of Capecitabine Main Raw Materials
6.1.2 Capecitabine Main Raw Materials Price Analysis
6.1.3 Capecitabine Raw Materials Major Suppliers
6.1.4 Capecitabine Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Capecitabine
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Capecitabine Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Capecitabine Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Capecitabine Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Capecitabine Distributors/Traders List in India
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Capecitabine
Table Product Specifications of Capecitabine
Figure India Capecitabine Sales (volume) for Each Type (2013-2023)
Figure India Capecitabine Sales Market Share by Types in 2017
Table Types of Capecitabine
Figure Product Picture of 500 mg
Table Major Players of 500 mg
Figure Product Picture of 150 mg
Table Major Players of 150 mg
Figure India Capecitabine Sales Present Situation and Outlook by Applications (2013-2023)
Figure India Capecitabine Sales Market Share by Applications in 2017
Table Applications of Capecitabine
Figure Breast Cancer Examples
Figure Colorectal cancer Examples
Figure Stomach Cancer Examples
Figure India Capecitabine Revenue (Million USD) Status and Forecast (2013-2023)
Figure India Capecitabine Sales (Volume) Status and Forecast (2013-2023)
Table India Capecitabine Sales by Players (2013-2018)
Table India Capecitabine Sales Market Share (%) by Players (2013-2018)
Figure India Capecitabine Sales Market Share by Players in 2016
Figure India Capecitabine Sales Market Share by Players in 2017
Table India Capecitabine Revenue (Million USD) by Players (2013-2018)
Table India Capecitabine Revenue Market Share (%) by Players (2013-2018)
Figure India Capecitabine Revenue Market Share by Players in 2016
Figure India Capecitabine Revenue Market Share by Players in 2017
Figure India Capecitabine Average Price by Players in 2017
Table India Capecitabine Manufacturing Base Distribution and Sales Area by Players
Table Players Capecitabine Product Types
Figure Capecitabine Market Share of Top 3 Players in 2017
Figure Capecitabine Market Share of Top 5 Players in 2017
Table India Capecitabine Sales by Type (2013-2018)
Table India Capecitabine Sales Market Share by Type (2013-2018)
Figure India Capecitabine Sales Market Share by Type in 2013
Figure India Capecitabine Sales Market Share by Type in 2017
Table India Capecitabine Revenue (Million USD) by Type (2013-2018)
Table India Capecitabine Revenue Market Share by Type (2013-2018)
Figure India Capecitabine Revenue Market Share by Type in 2013
Figure India Capecitabine Revenue Market Share by Type in 2017
Table India Capecitabine Price by Type (2013-2018)
Table India Capecitabine Sales by Application (2013-2018)
Table India Capecitabine Sales Market Share by Application (2013-2018)
Figure India Capecitabine Sales Market Share by Application (2013-2018)
Figure India Capecitabine Sales Market Share by Application in 2017
Table India Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Capecitabine Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Capecitabine Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Capecitabine Market Share (2012-2017)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hikma Capecitabine Market Share (2012-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hengrui Medicine Capecitabine Market Share (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Capecitabine Market Share (2012-2017)
Table Reliance Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Market Share (2012-2017)
Table Hetero Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Capecitabine Market Share (2012-2017)
Figure India Capecitabine Sales and Growth Rate Forecast (2018-2023)
Figure India Capecitabine Revenue and Growth Rate Forecast (2018-2023)
Figure India Capecitabine Price Trend Forecast (2018-2023)
Table India Capecitabine Sales Forecast by Type (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Type (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Type in 2023
Table India Capecitabine Sales Forecast by Application (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Application (2018-2023)
Figure India Capecitabine Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Capecitabine Main Raw Materials Price Trend
Table Capecitabine Raw Materials Major Suppliers List
Figure Production Cost Structure of Capecitabine
Figure Capecitabine Manufacturing Process/Method
Figure Capecitabine Value Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players in 2017
Table Major Buyers of Capecitabine
Table Capecitabine Distributors/Traders List in India
  • Global Methotrexate Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 16-Jan-2019        Price: US 3480 Onwards        Pages: 116
    Methotrexate is kwon as Amethopterin, Methotrexate Sodium, and MTX. It is a yellow or orange, crystalline powder, and made into methotrexate tablets and methotrexate for injection. Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Scope of the Report: This report focuses on the Methotrexate in global market, especially in North America, Europe and......
  • Global Oncology Drugs Market Insights, Forecast to 2025
    Published: 15-Jan-2019        Price: US 3900 Onwards        Pages: 119
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%. The ......
  • Global Lymphoma Drugs Market Insights, Forecast to 2025
    Published: 15-Jan-2019        Price: US 3900 Onwards        Pages: 118
    Lymphoma is cancer that begins in infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes change and grow out of control. The China average price of Lymphoma Drugs is in the decreasing trend, from 1560 USD/Unit in 2013 to 1373 USD/Unit in 2017. With the situation of China economy, prices will be in decreasing trend in the following five years. ......
  • Global and Chinese Cyclophosphamide Industry, 2018 Market Research Report
    Published: 14-Jan-2019        Price: US 3000 Onwards        Pages: 150
    The 'Global and Chinese Cyclophosphamide Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Cyclophosphamide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cyclophosphamide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its de......
  • Global Kidney Cancer Drugs Market Insights, Forecast to 2025
    Published: 14-Jan-2019        Price: US 3900 Onwards        Pages: 149
    Kidney cancer, also known as renal cancer, is a type of cancer that starts in the cells in the kidney. The two most common types of kidney cancer are renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed. The different types of kidney cancer (such as RCC and TCC) develop in different ways, meaning that the diseases have different long term outcomes, and need to be staged and treated in different ......
  • Global and Chinese Megestrol Industry, 2018 Market Research Report
    Published: 12-Jan-2019        Price: US 3000 Onwards        Pages: 149
    The 'Global and Chinese Megestrol Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Megestrol industry with a focus on the Chinese market. The report provides key statistics on the market status of the Megestrol manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of the industry including its definition, application......
  • Global Hematological Malignancies Disease Market Data Survey Report 2025
    Published: 12-Jan-2019        Price: US 1500 Onwards        Pages: 86
    Summary The global Hematological Malignancies Disease market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing s......
  • Global Cancer Targeted Therapy Market Data Survey Report 2025
    Published: 12-Jan-2019        Price: US 1500 Onwards        Pages: 105
    Summary The global Cancer Targeted Therapy market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capac......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Multiple Myeloma Drugs Market 2018, Forecast to 2023
    Published: 11-Jan-2019        Price: US 4880 Onwards        Pages: 135
    Multiple myeloma is a cancer that forms in a type of white blood cell that is called a plasma cell. Plasma cells help to fight infections by making antibodies. Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer cells produce abnormal proteins that can cause complications. For people with multiple myeloma who require treatment, a number of treatments are available to help control the d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs